Latest Listings And Ipos News

ResMed Inc. has updated the foreign exchange rate impacting its upcoming dividend payment to Australian CDI holders, reflecting currency volatility and tax treaty benefits.

Avecho Biotechnology has responded to an ASX price query, confirming no undisclosed information exists to explain recent trading spikes, while highlighting market speculation linked to its Phase III CBD insomnia trial.

Laramide Resources Ltd. has acknowledged a delayed filing of a director's interest notice due to internal illness, prompting an ASX inquiry and procedural upgrades to prevent future lapses.

Microequities Asset Management Group Limited has reported a robust 46.4% increase in profit after tax for the half-year ended December 2024, alongside a record $650 million in Funds Under Management and a raised interim dividend.

WAM Capital Limited has delivered a robust half-year performance ending December 2024, posting a 40% increase in net profit and declaring a steady interim dividend of 7.75 cents per share. The company’s investment portfolio outperformed key ASX indices, underpinning strong shareholder returns.

Wellnex Life Limited has locked in A$9 million in conditional commitments to support its proposed dual listing on the London Stock Exchange’s AIM market, alongside launching a 1:1 entitlement offer for existing shareholders.

Abacus Storage King reported a striking turnaround with a $67.8 million net profit for H1 2024, up from just $0.4 million a year earlier, alongside a raised interim distribution reflecting robust growth in the self-storage sector.

FireFly Metals Ltd reports a significant 42% increase in mineral resources at its Green Bay Copper-Gold Project, underpinned by robust drilling results and a well-capitalized balance sheet with over A$84 million in cash and liquid assets.

Charter Hall Retail REIT reported a 3.0% same property net property income growth and a stable 98.7% occupancy rate in its 2025 half-year results, while integrating the Hotel Property Investments acquisition to enhance future income growth.

Pure Foods Tasmania Limited (ASX: PFT) will recommence trading on the ASX from 14 February 2025 following the lifting of its suspension after submitting reissued financial statements with an unqualified audit opinion.

Pure Foods Tasmania has executed key loan extensions with Commonwealth Bank and outlined a comprehensive turnaround strategy to address its financial challenges, despite ongoing material uncertainty over its going concern status.

Recce Pharmaceuticals has temporarily paused trading of its securities, signaling a potentially significant development pending further disclosure.